Companies / BOC Sciences / Cendakimab
BOC Sciences

Cendakimab | BOC Sciences

Cendakimab is a humanized monoclonal antibody directed against IL-13. Cendakimab targets IL-13 and inhibits its binding to both IL-13-receptor specific subtypes (IL-13-R_1 and IL-13-R_2). Cendakimab has been used in the research of eosinophilic esophagitis.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.